Janna Hachmann is the COO and co-founder of Captain T Cell, a Berlin-Schönefeld-based biotech pioneering next-generation TCR-T cell therapies for solid tumors. She holds a Master’s degree in Biochemistry from Freie Universität Berlin and a Ph.D. in Biomedical Sciences from Sanford Burnham Prebys Medical Discovery Institute in La Jolla, CA. Janna combines scientific expertise with operational leadership to advance cutting-edge immunotherapies. Her career spans antibody discovery, healthcare consulting, and technology transfer, giving her a broad perspective on turning science into real-world impact. Janna thrives at the intersection of science, strategy, and entrepreneurship.